Black Rock Inc. Renovo Rx, Inc. Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 20,840 shares of RNXT stock, worth $24,174. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,840
Previous 21,388
2.56%
Holding current value
$24,174
Previous $48,000
43.75%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RNXT
# of Institutions
12Shares Held
1.3MCall Options Held
0Put Options Held
0-
Bank Of The West975KShares$1.13 Million0.27% of portfolio
-
Nixon Peabody Trust CO Boston, MA97.2KShares$112,7110.01% of portfolio
-
Geode Capital Management, LLC Boston, MA67.1KShares$77,8220.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA56.7KShares$65,8140.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA49.2KShares$57,1090.0% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $10.5M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...